Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 75 | 0 |
| Gross Profit | N/A | N/A | N/A | 75 | N/A |
| Operating Expenses | 10,055 | 21,491 | 34,196 | 14,121 | 68 |
| Operating Income | -10,055 | -21,491 | -34,196 | -14,046 | -68 |
| Interest Expense | 396 | 108 | 218 | 187 | 0 |
| Other Income | -427 | 332 | -3,160 | 784 | -17,211 |
| Pre-tax Income | -10,877 | -21,267 | -37,574 | -13,449 | -17,280 |
| Net Income Continuous | -10,877 | -21,267 | -37,574 | -13,449 | -17,280 |
| Net Income | $-10,877 | $-21,267 | $-37,574 | $-13,449 | $-17,280 |
| EPS Basic Total Ops | -5.65 | -16.56 | -52.60 | -24.60 | -112.60 |
| EPS Basic Continuous Ops | -5.65 | -16.56 | -52.57 | -24.64 | -184.32 |
| EPS Diluted Total Ops | -5.65 | -16.56 | -52.60 | -24.60 | -112.60 |
| EPS Diluted Continuous Ops | -5.65 | -16.56 | -52.57 | -24.64 | -184.32 |
| EPS Diluted Before Non-Recurring Items | -5.65 | -17.80 | N/A | N/A | N/A |
| EBITDA(a) | $-8,838 | $-20,490 | $-33,195 | $-13,599 | $-68 |